MEG3 and colorectal carcinoma: The lncRNA maternally expressed gene 3 (MEG3) reduces glycolytic levels in CRC cells by degrading the expression of c-myc, including down-regulating the expressions of glycolysis-related enzymes such as LDHA, PKM2, and HK2 (Zuo et al., 2020).